NCT07538050 2026-04-20
SCALE AIM 2
The Cleveland Clinic
Phase NA Not yet recruiting
Clinical Trials
8 trialsNCT05012813 2026-03-09
Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer
OHSU Knight Cancer Institute
Phase NA Completed
NCT07225530 2026-02-25
(iSTAR)
Columbia University
Phase NA Recruiting
NCT02132845 2021-02-04
Next Generation Sequence Target-Directed Therapy in Treating Patients With Cancer
Fox Chase Cancer Center
Phase NA Completed
NCT02094872 2020-01-02
Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic
Yale University
Phase 2 Completed
NCT02132884 2019-09-04
Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Fox Chase Cancer Center
Phase NA Terminated
NCT03049358 2019-02-05
Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer
Stanford University
Phase NA Terminated
NCT00324831 2013-12-18
GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
Phase 3 Suspended